1
Clinical Trials associated with Respiratory Syncytial Virus Vaccine(Sinocelltech)A Randomized, Double-blind, Placebo-controlled Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Recombinant Respiratory Syncytial Virus Vaccine (SCTV02) in Healthy Adults ≥18 Years of Age
This is a randomised, double-blind, placebo-controlled Phase 1/2 clinical trial to evaluate the safety, tolerability and immunogenicity of recombinant respiratory syncytial virus in participants aged 18 years and older.
100 Clinical Results associated with Respiratory Syncytial Virus Vaccine(Sinocelltech)
100 Translational Medicine associated with Respiratory Syncytial Virus Vaccine(Sinocelltech)
100 Patents (Medical) associated with Respiratory Syncytial Virus Vaccine(Sinocelltech)
100 Deals associated with Respiratory Syncytial Virus Vaccine(Sinocelltech)